4.4 Article

Complement component 4A protein levels are negatively related to frontal volumes in patients with schizophrenia spectrum disorders

Related references

Note: Only part of the references are listed.
Review Neurosciences

Neuroimaging in schizophrenia: an overview of findings and their implications for synaptic changes

Oliver D. Howes et al.

Summary: This article provides an overview of the evidence on structural and metabolic brain alterations in schizophrenia, suggesting the presence of lower synaptic density in certain brain regions. However, there are still gaps in evidence that need further investigation.

NEUROPSYCHOPHARMACOLOGY (2023)

Article Psychiatry

Association of Complement and Coagulation Pathway Proteins With Treatment Response in First-Episode Psychosis: A Longitudinal Analysis of the OPTiMiSE Clinical Trial

Subash Raj Susai et al.

Summary: The levels of plasma complement and coagulation pathway proteins may be related to the response to antipsychotic treatment. Higher levels of several complement and coagulation pathway proteins are associated with a reduction in psychotic symptoms and an improvement in functioning.

SCHIZOPHRENIA BULLETIN (2023)

Article Immunology

Relationship of selective complement markers with schizophrenia

Abdull Jalil Mohd Asyraf et al.

Summary: The study found that complement markers C3 and C4 may be potential peripheral biomarkers in schizophrenia. These markers were significantly elevated in patients and subjects with elevated CRP, and positively correlated with BMI. Schizophrenia, BMI, and CRP were found to be significant predictors for C3 and C4 levels.

JOURNAL OF NEUROIMMUNOLOGY (2022)

Article Multidisciplinary Sciences

Mapping genomic loci implicates genes and synaptic biology in schizophrenia

Vassily Trubetskoy et al.

Summary: In this study, a two-stage genome-wide association study was conducted to identify common variants associated with schizophrenia. The results revealed 287 distinct genomic loci and 120 genes likely to be involved in the development of schizophrenia. This research provides valuable insights into the pathophysiology of schizophrenia and offers a resource for further mechanistic studies.

NATURE (2022)

Article Psychiatry

The neurobiological characterization of distinct cognitive subtypes in early-phase schizophrenia-spectrum disorders

P. P. Oomen et al.

Summary: This study aimed to identify cognitive subtypes in patients with early-phase schizophrenia-spectrum disorders (SSD) and evaluate their differences in clinical and brain volumetric measures. The results revealed three distinct cognitive clusters, characterized by differences in cortical regional brain volume and cortical thickness.

SCHIZOPHRENIA RESEARCH (2022)

Article Neurosciences

Complement component C4 levels in the cerebrospinal fluid and plasma of patients with schizophrenia

Juan A. Gallego et al.

Summary: This study found a significant increase in CSF C4 levels in patients with schizophrenia after adjusting for sex and age, with a high correlation observed between CSF C4 levels and age. Plasma C4 levels did not show significant differences between groups, and CSF and plasma C4 levels were not significantly correlated. The use of CSF samples is critical for a comprehensive understanding of complement C4 abnormalities in schizophrenia.

NEUROPSYCHOPHARMACOLOGY (2021)

Article Psychiatry

Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence

David Mongan et al.

Summary: This study investigates the potential of plasma proteomic biomarkers in predicting transition to psychotic disorder in at-risk individuals and adolescent psychotic experiences in the general population. Models based on proteomic data showed excellent predictive performance in high-risk individuals and fair performance in the general population. Predictive models using proteomic biomarkers could contribute to personalized prognosis and stratification strategies for those at risk of psychosis.

JAMA PSYCHIATRY (2021)

Article Biochemistry & Molecular Biology

Trajectory of change in brain complement factors from neonatal to young adult humans

Rachel E. H. Sager et al.

Summary: The immune system components play a role in regulating synapse formation and refinement in neurodevelopment. The complement pathway, associated with cell lysis and phagocytosis, is involved in synaptic elimination. Changes in complement activity during human development, particularly during adolescence, may be linked to the onset of neurodevelopmental disorders such as autism or schizophrenia.

JOURNAL OF NEUROCHEMISTRY (2021)

Article Neurosciences

Overexpression of schizophrenia susceptibility factor human complement C4A promotes excessive synaptic loss and behavioral changes in mice

Melis Yilmaz et al.

Summary: Overexpression of complement C4A is associated with schizophrenia risk. Investigation using a novel mouse model showed that increased expression of C4A leads to abnormal synaptic pruning and behavior, suggesting its importance as a therapeutic target.

NATURE NEUROSCIENCE (2021)

Review Psychiatry

Abnormal synaptic pruning during adolescence underlying the development of psychotic disorders

Monique Germann et al.

Summary: The review highlights the importance of excessive synaptic pruning in schizophrenia and recent advancements in the field, focusing on the role of astrocytes and complement-mediated microglial pruning in disease onset and cognitive symptoms. The pruning machinery may be a potential target for early treatment and prevention of schizophrenia.

CURRENT OPINION IN PSYCHIATRY (2021)

Article Psychiatry

Complement C4 associations with altered microbial biomarkers exemplify gene-by-environment interactions in schizophrenia

Emily G. Severance et al.

Summary: The study found that complement C4 genes are associated with susceptibility to infections and dysbiotic microbiome in schizophrenia, with different C4 haplotypes showing varying associations with microbial infections. These results support the role of immune system mechanisms in gene-environment interactions in the development of schizophrenia.

SCHIZOPHRENIA RESEARCH (2021)

Review Genetics & Heredity

Schizophrenia: Complement Cleaning or Killing

Jirrine T. T. Hogenaar et al.

Summary: Schizophrenia is a psychiatric disorder with a typical onset in adolescence or young adulthood, characterized by reduced cortical synaptic densities which may involve excessive pruning by the complement system. Further research is needed to assess the impact of complement overactivity on different phenotypic features of schizophrenia and to understand the exact mechanisms involved.

GENES (2021)

Article Biochemistry & Molecular Biology

Elevated expression of complement C4 in the mouse prefrontal cortex causes schizophrenia-associated phenotypes

Melanie Druart et al.

Summary: Accumulated evidence suggests that high expression variants of the C4 gene are associated with susceptibility to schizophrenia. Overexpression of C4 in the mouse prefrontal cortex leads to reduced spine density and glutamatergic input to pyramidal cells. These deficits may be attributed to decreased dendritic spine formation and hypofunction of NMDA receptors in juvenile C4-OE mice.

MOLECULAR PSYCHIATRY (2021)

Article Neurosciences

Brain gene co-expression networks link complement signaling with convergent synaptic pathology in schizophrenia

Minsoo Kim et al.

Summary: The study found no significant genetic enrichment among known complement system genes for schizophrenia (SCZ), but genes downregulated when C4A expression increases exhibit strong and specific genetic enrichment for SCZ risk. This indicates that synaptic pathways, rather than the complement system, are the driving force conferring SCZ risk. Brain genetic co-expression networks pinpoint specific and convergent synaptic pathways through which genetic variation at the C4 locus imparts risk for schizophrenia.

NATURE NEUROSCIENCE (2021)

Article Neurosciences

Genetically Predicted Brain C4A Expression Is Associated With TSPO and Hippocampal Morphology

Tania Da Silva et al.

Summary: This study quantified genetically predicted brain C4A expression and its association with microglial marker (TSPO) and hippocampal morphology in living human brain for the first time. Individuals at clinical high risk showed significantly lower C4A expression compared to healthy control subjects, and both sex and cannabis use were found to have effects on brain TSPO.

BIOLOGICAL PSYCHIATRY (2021)

Article Biochemistry & Molecular Biology

In vivo evidence of lower synaptic vesicle density in schizophrenia

Rajiv Radhakrishnan et al.

Summary: Lower synaptic vesicle density was observed in several brain regions in schizophrenia (SCZ) patients compared to healthy controls in this study, as indicated by [C-11]UCB-J PET imaging. Frontal synaptic vesicle density was found to be correlated with severity of psychotic symptoms and cognitive performance.

MOLECULAR PSYCHIATRY (2021)

Article Psychiatry

Synapse Pathology in Schizophrenia: A Meta-analysis of Postsynaptic Elements in Postmortem Brain Studies

Amber Berdenis van Berlekom et al.

SCHIZOPHRENIA BULLETIN (2020)

Review Biochemistry & Molecular Biology

The complement system in schizophrenia: where are we now and what's next?

Julia J. Woo et al.

MOLECULAR PSYCHIATRY (2020)

Article Multidisciplinary Sciences

Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats

Ellis Chika Onwordi et al.

NATURE COMMUNICATIONS (2020)

Article Multidisciplinary Sciences

Complement genes contribute sex-biased vulnerability in diverse disorders

Nolan Kamitaki et al.

NATURE (2020)

Article Genetics & Heredity

Effects of complement gene-set polygenic risk score on brain volume and cortical measures in patients with psychotic disorders and healthy controls

Jessica F. Holland et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2020)

Article Immunology

Increased Macrophages and C1qA, C3, C4 Transcripts in the Midbrain of People With Schizophrenia

Tertia D. Purves-Tyson et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Psychiatry

Investigation of peripheral complement factors across stages of psychosis

Liliana Laskaris et al.

SCHIZOPHRENIA RESEARCH (2019)

Article Neurosciences

Quantitative assessment of structural image quality

Adon F. G. Rosen et al.

NEUROIMAGE (2018)

Review Biochemistry & Molecular Biology

The complement system: a gateway to gene-environment interactions in schizophrenia pathogenesis

V. L. Nimgaonkar et al.

MOLECULAR PSYCHIATRY (2017)

Article Multidisciplinary Sciences

Schizophrenia risk from complex variation of complement component 4

Aswin Sekar et al.

NATURE (2016)

Article Biochemical Research Methods

Effects of olanzapine on serum protein phosphorylation patterns in patients with schizophrenia

Julian A. Jaros et al.

PROTEOMICS CLINICAL APPLICATIONS (2015)

Article Medicine, General & Internal

Simvastatin augmentation for recent-onset psychotic disorder: A study protocol

Marieke J. H. Begemann et al.

BBA CLINICAL (2015)

Article Multidisciplinary Sciences

Biological insights from 108 schizophrenia-associated genetic loci

Stephan Ripke et al.

NATURE (2014)

Article Multidisciplinary Sciences

Extraordinary neoteny of synaptic spines in the human prefrontal cortex

Zdravko Petanjek et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Psychiatry

International Consensus Study of Antipsychotic Dosing

David M. Gardner et al.

AMERICAN JOURNAL OF PSYCHIATRY (2010)

Article Biochemistry & Molecular Biology

High-throughput analysis of the C4 polymorphism by a combination of MLPA and isotype-specific ELISA's

Diana Wouters et al.

MOLECULAR IMMUNOLOGY (2009)

Article Biochemical Research Methods

Complexes between C1q and C3 or C4: Novel and specific markers for classical complement pathway activation

D Wouters et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2005)

Article Medical Laboratory Technology

Reference distributions for complement proteins C3 and C4: A practical, simple and clinically relevant approach in a large cohort

RF Ritchie et al.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2004)

Article Immunology

Total C4B deficiency due to gene deletion and gene conversion in a patient with severe infections

T Jaatinen et al.

CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY (2003)